Optogenetics: using light to test brain circuits
Light-sensitive proteins let researchers manipulate neurons and investigate cause-and-effect relationships.

Leitura autorizada · 3 crédito(s) restante(s)
Seeing neurons active at the same time does not prove that they cause a memory or movement. Optogenetics combines genetics and light to alter selected cells and test what happens when they are stimulated.
Peter Hegemann and Georg Nagel studied proteins that let single-celled algae respond to light. Channelrhodopsin forms a channel in a cell membrane and, when illuminated, lets ions—electrically charged particles—cross. Karl Deisseroth and colleagues adapted this property for neurons.
In 2005, Edward Boyden, Feng Zhang, Ernst Bamberg, Nagel and Deisseroth published a demonstration in Nature Neuroscience that activated mammalian neurons with light pulses. The method lets researchers manipulate defined circuits and observe effects on brain activity and behavior.
In 2026, Hegemann, Nagel and Deisseroth received the Nobel Prize in Physiology or Medicine for discoveries about light-gated ion channels and the development of optogenetics. The method is primarily a research tool: animal results do not mean an equivalent clinical treatment is available.
The evidence shows how precise intervention can test neural circuits, but it does not turn thoughts into switches. The Nobel’s institutional announcement lists no individual author; Boyden and colleagues’ study and a review by Pama, Colzato and Hommel explain the method and its limits.
Key points
- Optogenetics combines genetics and light to alter selected cells.
- Channelrhodopsin is a light-sensitive protein that lets ions cross a membrane.
- The method is a research tool, not a general clinical treatment.

Comments
No comments have been published yet.
Sign in with a subscription to comment.